United States· US:24478-102_32c90701-fe4a-4d5a-b3bb-e9ccf0416ece
Dyanavel XR
A amfetamine product containing amphetamine, registered in United States by NextWave Pharmaceuticals, Inc. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Amfetamine is registered in 3 of 19 countries.
Countries holding a registration under ATC N06BA01 (amfetamine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Amfetamine · ATC N06BA01
3 / 19 countries
- Canada
- Norwayprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- AMPHETAMINE
- Manufacturer
- NextWave Pharmaceuticals, Inc
- Country
- United States (US)
- ATC code
- N06BA01
- ATC class
- Amfetamine
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1124478-102-01
- ndc1124478-102-02
- ndc1124478102011 BOTTLE in 1 CARTON (24478-102-01) / 464 mL in 1 BOTTLE
- ndc1124478102021 BOTTLE in 1 CARTON (24478-102-02) / 60 mL in 1 BOTTLE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
132 interactions on record for amfetamine.
Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Amfetamine · interactions on record
132 records
- 16 severe
- 100 moderate
- 16 info
Most severe, free to view
- FenfluramineA08AA02severe
- DexfenfluramineA08AA04severe
- SibutramineA08AA10severe
- ProcarbazineL01XB01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Amfetamine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f6c219de-2f97-4fde-8fa8-94c3f893d5ca GET /v1/drugs/f6c219de-2f97-4fde-8fa8-94c3f893d5ca?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "2.5",
"substance": "AMPHETAMINE",
"productndc": "24478-102",
"dosage_form": "SUSPENSION, EXTENDED RELEASE",
"dea_schedule": "CII",
"strength_unit": "mg/mL",
"application_number": "NDA208147",
"marketing_category": "NDA"
}See everything about amfetamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.